Brian P. Quinn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Brian P. Quinn has a total of 128 co-authors. Here are the top co-authors by number of shared publications:
Lisa Bergersen
8 shared publicationsKimberlee Gauvreau
Department of Cardiology Boston Children's Hospital Boston Massachusetts USA
4 shared publicationsSara M. Trucco
Heart Institute, UPMC Children's Hospital of Pittsburgh and Department of Pediatrics University of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA
4 shared publications- Bryan H. Goldstein
University of Pittsburgh School of Medicine
3 shared publications - George T. Nicholson
Vanderbilt University Medical Center
3 shared publications Juan C. Ibla
3 shared publications
Latest Publications
- 21 August 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (9) , 686
Innovations in transcatheter interventions for hypoplastic left heart syndrome and borderline left heart structures from fetal to neonatal life: current evidence and systematic review of recent advances (2016–2025)
- 21 August 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (9) , 686
Innovations in transcatheter interventions for hypoplastic left heart syndrome and borderline left heart structures from fetal to neonatal life: current evidence and systematic review of recent advances (2016–2025)
- 31 December 2025
- Published by Wiley in Pediatric Anesthesia
- Vol. 36 (4) , 379-387
Incidence of High Severity Anesthesia Related Adverse Events With Increasing PREDIC 3 T Risk Category in Congenital Cardiac Catheterization: A Review of the C3PO Database
Background: Safe and effective anesthesia is critical for the care of pediatric patients with congenital heart disease undergoing cardiac catheterization. Over the past two decades, there has been a significant transition from primarily diagnostic procedures to complex interventional cases, accompanied by a shift from operator‐managed sedation to anesthesia administered by a trained anesthesiologist. Aims: The aim of our study is to explore the incidence of high severity anesthesia related adverse events (ARAE) and whether these rates correlate with Procedural Risk in Congenital Cardiac Catheterization (PREDIC 3 T) case‐type risk categories. Higher risk categories have been shown to correlate with high severity procedural related adverse events. Methods: A multicenter, retrospective cohort study utilized data collected prospectively in the Congenital Cardiac Catheterization Project on Outcomes (C3PO). This study, encompassing 18 contributing institutions, analyzed data from January 1, 2019 to December 31, 2023. Rates of 17 specific ARAE were stratified via PREDIC 3 T category. Results: During the study period, 38, 021 cardiac catheterizations were included in this analysis. A total of 321 ARAE of any severity (level 1–5) were recorded, for an overall rate of 0.8% (CI, 0.7%–0.9%). Of these 321 ARAE, 160 were high severity (level 3bc/4/5), yielding a rate of 0.4%. Rates of high severity ARAE by PREDIC 3 T risk category (0,1, 2, 3, 4, 5) were found to be 0.2%. 0.4%, 0.5%, 0.3%. 0.8%, and 0.7%, respectively. Multivariable logistic regression analyses identified weight under 10 kg, hemodynamic vulnerability score (HVS) ≥ 1, and PREDIC 3 T risk category 5 procedures as factors associated with higher odds of experiencing a high severity ARAE. Conclusions: The overall rate of ARAE, including high severity ARAE, was found to be increased in higher PREDIC 3 T risk category procedures. Both patient and procedural factors contribute to ARAE in the congenital cardiac catheterization laboratory. Clinical Trial Number and Registry: Not applicable.
- 31 December 2025
- Published by Wiley in Pediatric Anesthesia
- Vol. 36 (4) , 379-387
Incidence of High Severity Anesthesia Related Adverse Events With Increasing PREDIC 3 T Risk Category in Congenital Cardiac Catheterization: A Review of the C3PO Database
Background: Safe and effective anesthesia is critical for the care of pediatric patients with congenital heart disease undergoing cardiac catheterization. Over the past two decades, there has been a significant transition from primarily diagnostic procedures to complex interventional cases, accompanied by a shift from operator‐managed sedation to anesthesia administered by a trained anesthesiologist. Aims: The aim of our study is to explore the incidence of high severity anesthesia related adverse events (ARAE) and whether these rates correlate with Procedural Risk in Congenital Cardiac Catheterization (PREDIC 3 T) case‐type risk categories. Higher risk categories have been shown to correlate with high severity procedural related adverse events. Methods: A multicenter, retrospective cohort study utilized data collected prospectively in the Congenital Cardiac Catheterization Project on Outcomes (C3PO). This study, encompassing 18 contributing institutions, analyzed data from January 1, 2019 to December 31, 2023. Rates of 17 specific ARAE were stratified via PREDIC 3 T category. Results: During the study period, 38, 021 cardiac catheterizations were included in this analysis. A total of 321 ARAE of any severity (level 1–5) were recorded, for an overall rate of 0.8% (CI, 0.7%–0.9%). Of these 321 ARAE, 160 were high severity (level 3bc/4/5), yielding a rate of 0.4%. Rates of high severity ARAE by PREDIC 3 T risk category (0,1, 2, 3, 4, 5) were found to be 0.2%. 0.4%, 0.5%, 0.3%. 0.8%, and 0.7%, respectively. Multivariable logistic regression analyses identified weight under 10 kg, hemodynamic vulnerability score (HVS) ≥ 1, and PREDIC 3 T risk category 5 procedures as factors associated with higher odds of experiencing a high severity ARAE. Conclusions: The overall rate of ARAE, including high severity ARAE, was found to be increased in higher PREDIC 3 T risk category procedures. Both patient and procedural factors contribute to ARAE in the congenital cardiac catheterization laboratory. Clinical Trial Number and Registry: Not applicable.
- Open Access
- 13 November 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (12)
Percutaneous Pulmonary Valve Perforation in Pulmonary Atresia With Intact Ventricular Septum: Multicenter Comparison of Radiofrequency Versus Chronic Total Occlusion Wires
- 13 November 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (12)
Open AccessPercutaneous Pulmonary Valve Perforation in Pulmonary Atresia With Intact Ventricular Septum: Multicenter Comparison of Radiofrequency Versus Chronic Total Occlusion Wires
- Open Access
- 15 August 2025
- Published by Elsevier in Intelligence-Based Medicine
- Vol. 12
Risk-based clinical scheduling tool for congenital cardiac catheterization procedures
- 15 August 2025
- Published by Elsevier in Intelligence-Based Medicine
- Vol. 12
Open AccessRisk-based clinical scheduling tool for congenital cardiac catheterization procedures
- 28 March 2025
- Published by Springer Nature in Pediatric Cardiology
- Vol. 47 (2) , 684-695
Congenital Cardiac Catheterization Risk Assessment in Infants Under 2.5 kg
Premature and small-for-gestational-age neonates with congenital heart disease increasingly require congenital cardiac catheterization (CCC). These patients present unique procedural and patient-specific risks that standard risk models do not fully capture. This study aims to assess risk in infants < 2.5 kg undergoing CCC, further stratifying by procedural type to better understand predictors of clinically meaningful adverse events (CMAE). Patient and Procedural data were collected on diagnostic and interventional catheterization procedures for infants < 2.5 kg from the Congenital Cardiac Catheterization Project on Outcomes (C3PO) registry between 2014 and 2022. Cases were stratified into historical (2014–2018) and modern (2019–2022) eras and further categorized into PDA closure and ‘All Other Cases’. Multivariable logistic regression assessed associations between covariates and the risk of CMAE. Analysis included 1,345 cases. In the modern era, PDA closures (n = 898, 66.8%) had a lower CMAE rate at 3.6% versus 8.1% for ‘All Other Cases’ (P < 0.001). Among ‘All Other Cases’ (n = 447) 23% were diagnostic and 77% interventional, with CMAE rates of 7.7% and 6.4%, respectively. CMAE types varied, with PDA cases mainly experiencing respiratory events (22%) and ‘All Other Cases’ showing higher rates of access complications (27%) and arrhythmias (29%). Risk in infants < 2.5 kg undergoing CCC is heavily dependent on procedural type and specific patient factors, highlighting the need for tailored risk assessment tools. This study, the largest to date in this population, emphasizes the importance of individualized care plans to improve outcomes.
- 28 March 2025
- Published by Springer Nature in Pediatric Cardiology
- Vol. 47 (2) , 684-695
Congenital Cardiac Catheterization Risk Assessment in Infants Under 2.5 kg
Premature and small-for-gestational-age neonates with congenital heart disease increasingly require congenital cardiac catheterization (CCC). These patients present unique procedural and patient-specific risks that standard risk models do not fully capture. This study aims to assess risk in infants < 2.5 kg undergoing CCC, further stratifying by procedural type to better understand predictors of clinically meaningful adverse events (CMAE). Patient and Procedural data were collected on diagnostic and interventional catheterization procedures for infants < 2.5 kg from the Congenital Cardiac Catheterization Project on Outcomes (C3PO) registry between 2014 and 2022. Cases were stratified into historical (2014–2018) and modern (2019–2022) eras and further categorized into PDA closure and ‘All Other Cases’. Multivariable logistic regression assessed associations between covariates and the risk of CMAE. Analysis included 1,345 cases. In the modern era, PDA closures (n = 898, 66.8%) had a lower CMAE rate at 3.6% versus 8.1% for ‘All Other Cases’ (P < 0.001). Among ‘All Other Cases’ (n = 447) 23% were diagnostic and 77% interventional, with CMAE rates of 7.7% and 6.4%, respectively. CMAE types varied, with PDA cases mainly experiencing respiratory events (22%) and ‘All Other Cases’ showing higher rates of access complications (27%) and arrhythmias (29%). Risk in infants < 2.5 kg undergoing CCC is heavily dependent on procedural type and specific patient factors, highlighting the need for tailored risk assessment tools. This study, the largest to date in this population, emphasizes the importance of individualized care plans to improve outcomes.
- Open Access
- 17 December 2024
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (3) , 102434
Generating Risk Reduction Analytics in Complex Cardiac Care Environments (GR2AC3E): Risk Prediction in Congenital Catheterization
- 17 December 2024
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (3) , 102434
Open AccessGenerating Risk Reduction Analytics in Complex Cardiac Care Environments (GR2AC3E): Risk Prediction in Congenital Catheterization
- 1 March 2024
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 17 (3) , e012834
Catheterization for Congenital Heart Disease Adjustment for Risk Method II
BACKGROUND: Current metrics used to adjust for case mix complexity in congenital cardiac catheterization are becoming outdated due to the introduction of novel procedures, innovative technologies, and expanding patient subgroups. This study aims to develop a risk adjustment methodology introducing a novel, clinically meaningful adverse event outcome and incorporating a modern understanding of risk. METHODS: Data from diagnostic only and interventional cases with defined case types were collected for patients ≤18 years of age and ≥2.5 kg at all Congenital Cardiac Catheterization Project on Outcomes participating centers. The derivation data set consisted of cases performed from 2014 to 2017, and the validation data set consisted of cases performed from 2019 to 2020. Severity level 3 adverse events were stratified into 3 tiers by clinical impact (3a/b/c); the study outcome was clinically meaningful adverse events, severity level ≥3b (3bc/4/5). RESULTS: The derivation data set contained 15 224 cases, and the validation data set included 9462 cases. Clinically meaningful adverse event rates were 4.5% and 4.2% in the derivation and validation cohorts, respectively. The final risk adjustment model included age P value, 0.83; Brier score, 0.042). CONCLUSIONS: CHARM II (Congenital Heart Disease Adjustment for Risk Method II) risk adjustment methodology allows for equitable comparison of clinically meaningful adverse events among institutions and operators with varying patient populations and case mix complexity performing pediatric cardiac catheterization.
- 1 March 2024
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 17 (3) , e012834
Catheterization for Congenital Heart Disease Adjustment for Risk Method II
BACKGROUND: Current metrics used to adjust for case mix complexity in congenital cardiac catheterization are becoming outdated due to the introduction of novel procedures, innovative technologies, and expanding patient subgroups. This study aims to develop a risk adjustment methodology introducing a novel, clinically meaningful adverse event outcome and incorporating a modern understanding of risk. METHODS: Data from diagnostic only and interventional cases with defined case types were collected for patients ≤18 years of age and ≥2.5 kg at all Congenital Cardiac Catheterization Project on Outcomes participating centers. The derivation data set consisted of cases performed from 2014 to 2017, and the validation data set consisted of cases performed from 2019 to 2020. Severity level 3 adverse events were stratified into 3 tiers by clinical impact (3a/b/c); the study outcome was clinically meaningful adverse events, severity level ≥3b (3bc/4/5). RESULTS: The derivation data set contained 15 224 cases, and the validation data set included 9462 cases. Clinically meaningful adverse event rates were 4.5% and 4.2% in the derivation and validation cohorts, respectively. The final risk adjustment model included age P value, 0.83; Brier score, 0.042). CONCLUSIONS: CHARM II (Congenital Heart Disease Adjustment for Risk Method II) risk adjustment methodology allows for equitable comparison of clinically meaningful adverse events among institutions and operators with varying patient populations and case mix complexity performing pediatric cardiac catheterization.
- 14 July 2022
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 23 (10) , 822-830
ICU Admission Tool for Congenital Heart Catheterization (iCATCH): A Predictive Model for High Level Post-Catheterization Care and Patient Management
Objectives: Currently, there are no prediction tools available to identify patients at risk of needing high-complexity care following cardiac catheterization for congenital heart disease. We sought to develop a method to predict the likelihood a patient will require intensive care level resources following elective cardiac catheterization. Design: Prospective single-center study capturing important patient and procedural characteristics for predicting discharge to the ICU. Characteristics significant at the 0.10 level in the derivation dataset (July 1, 2017 to December 31, 2019) were considered for inclusion in the final multivariable logistic regression model. The model was validated in the testing dataset (January 1, 2020 to December 31, 2020). The novel pre-procedure cardiac status (PCS) feature, collection started in January 2019, was assessed separately in the final model using the 2019 through 2020 dataset. Setting: Tertiary pediatric heart center. Patients: All elective cases coming from home or non-ICU who underwent a cardiac catheterization from July 2017 to December 2020. Interventions: None. Measurements and Main Results: A total of 2,192 cases were recorded in the derivation dataset, of which 11% of patients (n = 245) were admitted to the ICU, while 64% (n = 1,413) were admitted to a medical unit and 24% (n = 534) were discharged home. In multivariable analysis, the following predictors were identified: 1) weight less than 5 kg and 5–9.9 kg, 2) presence of systemic illness, 3) recent cardiac intervention less than 90 days, and 4) ICU Admission Tool for Congenital Heart Catheterization case type risk categories (1–5), with C-statistics of 0.79 and 0.76 in the derivation and testing cohorts, respectively. The addition of the PCS feature fit into the final model resulted in a C-statistic of 0.79. Conclusions: The creation of a validated pre-procedural risk prediction model for ICU admission following congenital cardiac catheterization using a large volume, single-center, academic institution will improve resource allocation and prediction of capacity needs for this complex patient population.
- 14 July 2022
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 23 (10) , 822-830
ICU Admission Tool for Congenital Heart Catheterization (iCATCH): A Predictive Model for High Level Post-Catheterization Care and Patient Management
Objectives: Currently, there are no prediction tools available to identify patients at risk of needing high-complexity care following cardiac catheterization for congenital heart disease. We sought to develop a method to predict the likelihood a patient will require intensive care level resources following elective cardiac catheterization. Design: Prospective single-center study capturing important patient and procedural characteristics for predicting discharge to the ICU. Characteristics significant at the 0.10 level in the derivation dataset (July 1, 2017 to December 31, 2019) were considered for inclusion in the final multivariable logistic regression model. The model was validated in the testing dataset (January 1, 2020 to December 31, 2020). The novel pre-procedure cardiac status (PCS) feature, collection started in January 2019, was assessed separately in the final model using the 2019 through 2020 dataset. Setting: Tertiary pediatric heart center. Patients: All elective cases coming from home or non-ICU who underwent a cardiac catheterization from July 2017 to December 2020. Interventions: None. Measurements and Main Results: A total of 2,192 cases were recorded in the derivation dataset, of which 11% of patients (n = 245) were admitted to the ICU, while 64% (n = 1,413) were admitted to a medical unit and 24% (n = 534) were discharged home. In multivariable analysis, the following predictors were identified: 1) weight less than 5 kg and 5–9.9 kg, 2) presence of systemic illness, 3) recent cardiac intervention less than 90 days, and 4) ICU Admission Tool for Congenital Heart Catheterization case type risk categories (1–5), with C-statistics of 0.79 and 0.76 in the derivation and testing cohorts, respectively. The addition of the PCS feature fit into the final model resulted in a C-statistic of 0.79. Conclusions: The creation of a validated pre-procedural risk prediction model for ICU admission following congenital cardiac catheterization using a large volume, single-center, academic institution will improve resource allocation and prediction of capacity needs for this complex patient population.
- Open Access
- 6 April 2022
- Published by Infectious Disease and Control Branch (IDPCB) - Public Health Agency of Canada in Relevé des maladies transmissibles au Canada
- Vol. 48 (4) , 156-162
Éclosion multijuridictionnelle de COVID-19 associée à une veillée funèbre et à des funérailles dans une communauté des Premières Nations du nord de la Saskatchewan
- 6 April 2022
- Published by Infectious Disease and Control Branch (IDPCB) - Public Health Agency of Canada in Relevé des maladies transmissibles au Canada
- Vol. 48 (4) , 156-162
Open AccessÉclosion multijuridictionnelle de COVID-19 associée à une veillée funèbre et à des funérailles dans une communauté des Premières Nations du nord de la Saskatchewan